You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 41 No. 7, July 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Behavioral Efficacy of Haloperidol and Lithium Carbonate

A Comparison in Hospitalized Aggressive Children With Conduct Disorder

Magda Campbell, MD; Arthur M. Small, MD; Wayne H. Green, MD; Susan J. Jennings, MA; Richard Perry, MD; Walter G. Bennett, MD; Lillian Anderson, RN

Arch Gen Psychiatry. 1984;41(7):650-656.


Abstract

• The efficacy and safety of haloperidol, lithium carbonate, and placebo were critically assessed in 61 treatment-resistant, hospitalized children aged 5.2 to 12.9 years with diagnoses of conduct disorder, aggressive type. In this double-blind and well-controlled study, the optimal dosages of haloperidol ranged from 1.0 to 6.0 mg/day and those of lithium carbonate from 500 to 2,000 mg/day. For the assessment of behavioral changes and untoward effects, various rating scales were used in different settings. Both haloperidol and lithium carbonate were found to be significantly superior to placebo in decreasing behavioral symptoms. Although both medications were clinically effective, haloperidol was associated more often with untoward effects than was lithium carbonate.



Author Affiliations

From the Department of Psychiatry, New York University Medical Center, New York.


Footnotes

Accepted for publication Sept 18, 1983.

Deceased.

Read at the 20th annual meeting of the American College of Neuropsychopharmacology, San Diego, Dec 18, 1981.

Reprint requests to Department of Psychiatry, New York University Medical Center, 550 First Ave, New York, NY 10016 (Dr Campbell).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Scientifically Unsupported and Supported Interventions for Childhood Psychopathology: A Summary
Lilienfeld
Pediatrics 2005;115:761-764.
ABSTRACT | FULL TEXT  

Oppositional Defiant Disorder and Conduct Disorder: A Review Of The Past 10 Years, Part II
Burke et al.
Focus 2004;2:558-576.
ABSTRACT | FULL TEXT  

Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY), Part I: A Review
Schur et al.
Focus 2004;2:596-607.
ABSTRACT | FULL TEXT  

Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults
Greenhill et al.
Focus 2004;2:642-668.
ABSTRACT | FULL TEXT  

Youth Homicide: A Review of the Literature and a Blueprint for Action
Heide
Int J Offender Ther Comp Criminol 2003;47:6-36.
ABSTRACT  

Treating Today's Juvenile Homicide Offenders
Heide and Solomon
Youth Violence and Juvenile Justice 2003;1:5-31.
ABSTRACT  

Psychopharmacology and Aggression: II. A Meta-Analysis of Nonstimulant Medication Effects on Overt Aggression-Related Behaviors in Youth with SED
Connor et al.
Journal of Emotional and Behavioral Disorders 2003;11:157-168.
ABSTRACT  

Long-Term Safety and Efficacy of Risperidone for the Treatment of Disruptive Behavior Disorders in Children With Subaverage IQs
Turgay et al.
Pediatrics 2002;110:e34-34.
ABSTRACT | FULL TEXT  

A Double-Blind Placebo-Controlled Study of Lithium in Hospitalized Aggressive Children and Adolescents With Conduct Disorder
Malone et al.
Arch Gen Psychiatry 2000;57:649-654.
ABSTRACT | FULL TEXT  

Psychopharmacology: Novel Antipsychotic Medications in the Treatment of Children and Adolescents
Malone et al.
Psychiatr. Serv. 1999;50:171-174.
FULL TEXT  

The Pharmacotherapy of Human Aggression: A Review
Caley
Journal of Pharmacy Practice 1996;9:133-143.
ABSTRACT  

Cerebrospinal Fluid Monoamine Metabolites, Aggression, and Impulsivity in Disruptive Behavior Disorders of Children and Adolescents
Kruesi et al.
Arch Gen Psychiatry 1990;47:419-426.
ABSTRACT  

Cerebrospinal Fluid Monoamine Metabolite Levels in Male Arsonists
Virkkunen et al.
Arch Gen Psychiatry 1987;44:241-247.
ABSTRACT  

Cognitive Effects of Lithium Carbonate and Haloperidol in Treatment-Resistant Aggressive Children
Platt et al.
Arch Gen Psychiatry 1984;41:657-662.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.